Rooted In Research
Studies, Articles, and Insights from New Chapter TMS
Learn more about mental health, depression and TMS treatment
Transcranial magnetic stimulation (TMS), particularly repetitive TMS (rTMS), has emerged as a promising non-invasive neuromodulation technique for treating major depressive disorder (MDD), including cases with significant suicidal ideation and behavior. Over the past decade, a growing body of research has evaluated the efficacy, safety, and mechanisms of TMS in reducing suicidality among individuals with depression,…
Read MoreThe first FDA approval of TMS was in 2008 by Neuronetics (the company that manufactures the Neurostar device). In recent years there have been many other companies making TMS devices; the total is now over 10! The different TMS devices and companies publish different outcome rates, which is important to consider when you’re considering spending…
Read MoreComparing NeuroStar TMS to other established depression treatments
Read More
Navigation
GET HELP TODAY